Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1310307
European Journal of Endocrinology, Vol 131, Issue 3, 307-312
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolf, M.
Right arrow Articles by Greten, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wolf, M.
Right arrow Articles by Greten, H.

Interleukin 1β, tumor necrosis factor-{alpha} and interleukin 6 decrease nuclear thyroid hormone receptor capacity in a liver cell line

Matthias Wolf, Nils Hansen and Heiner Greten

Wolf M, Hansen N, Greten H. Interleukin 1β, tumor necrosis factor-{alpha} and interleukin 6 decrease nuclear thyroid hormone receptor capacity in a liver cell line. Eur J Endocrinol 1994;131:307–12. ISSN 0804–4643

Many of the acute inflammatory responses in critical illness are mediated by tumor necrosis factor-{alpha} (TNF-{alpha}), interleukin 1/3 (IL-1β) and interleukin 6 (IL-6). Furthermore, these cytokines are involved in mediating the characteristic changes of thyroid function during acute disease known as non-thyroidal illness. In the present studies we investigated in vitro whether TNF-{alpha}, IL-1β and IL-6 modify nuclear thyroid hormone receptor (TR) capacity and/or affinity. Regulation of TR synthesis was studied in the human hepatoma cell line Hep-G2. Subconfluent cells were incubated with recombinant cytokines in serum-free medium. Nuclear extracts were prepared by high-salt extraction of cell nuclei. Binding assays were performed with [125I]-triiodothyronine; bound and free hormone were separated by filtration. Interleukin 1β decreased TR capacity in a dose-dependent manner. Compared with unstimulated cells, the TR capacity was reduced to 87.9 ± 3.9% (p < 0.05), 80.1 ± 3.9% (p < 0.01) and 72.1 ± 5.1% (p < 0.01) after incubation with 0.1,1.0 and 100 µg/l IL-1β respectively. Interleukin 6 and TNF-{alpha} significantly reduced receptor capacity only at concentrations of 10 µg/l or higher and the magnitude of the reduction was lower than with IL-1β. The TR capacity was reduced to 81.2 ± 2.3% (p < 0.01) and 83.2 ± 6.6% (p < 0.05) after stimulation with 10 µg/l IL-6 or TNF-{alpha}. respectively. TR affinity was not altered significantly after stimulation with any of the cytokines. In conclusion, we present evidence that the capacity of hepatic nuclear TRs is regulated by IL-1β. IL-6 and TNF-{alpha}. As cellular reaction to thyroid hormone stimulation depends on the number of nuclear TRs, this mechanism may serve to restrict catabolic effects of thyroid hormones during acute illness.

M Wolf, Medizinische Kern- und Poliklinik, Universitäts-Krankenhaus Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany




This article has been cited by other articles:


Home page
J EndocrinolHome page
J Kwakkel, W M Wiersinga, and A Boelen
Interleukin-1{beta} modulates endogenous thyroid hormone receptor {alpha} gene transcription in liver cells
J. Endocrinol., August 1, 2007; 194(2): 257 - 265.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W.-X. Gu, P. H. Stern, L. D. Madison, and G.-G. Du
Mutual Up-Regulation of Thyroid Hormone and Parathyroid Hormone Receptors in Rat Osteoblastic Osteosarcoma 17/2.8 Cells
Endocrinology, January 1, 2001; 142(1): 157 - 164.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-Y. Lin, L. J. Martino, B. D. Wilcox, F. B. Davis, J. K. Gordinier, and P. J. Davis
Potentiation by Thyroid Hormone of Human IFN-{gamma}-Induced HLA-DR Expression
J. Immunol., July 15, 1998; 161(2): 843 - 849.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.